BRCA1 and neoplasm: We have demonstrated using high-resolution genomic profiling coupled with analysis of tumour phenotypes that the development of a subset of sporadic breast tumours is similar to that of tumours derived from BRCA1- or BRCA2 germline mutation carriers.